Conformationally altered p53: a novel Alzheimer's disease marker? (Q51900746)

17 April 2018

title

Conformationally altered p53: a novel Alzheimer's disease marker? (English)

1 reference

17 April 2018

1 reference

2

1 reference

17 April 2018

Stefano Govoni

12

1 reference

17 April 2018

Daniela Uberti

14

1 reference

17 April 2018

author name string

Lanni C

1

1 reference

17 April 2018

Mazzini G

3

1 reference

17 April 2018

Ranzenigo A

4

1 reference

17 April 2018

Polotti R

5

1 reference

17 April 2018

Sinforiani E

6

1 reference

17 April 2018

Olivari L

7

1 reference

17 April 2018

Barcikowska M

8

1 reference

17 April 2018

Styczynska M

9

1 reference

17 April 2018

Kuznicki J

10

1 reference

17 April 2018

Szybinska A

11

1 reference

17 April 2018

Memo M

13

1 reference

17 April 2018

language of work or name

English

0 references

publication date

7 August 2007

1 reference

17 April 2018

published in

Molecular Psychiatry

1 reference

17 April 2018

volume

13

1 reference

17 April 2018

issue

6

1 reference

17 April 2018

page(s)

641-647

1 reference

17 April 2018

Biomarkers of Alzheimer's disease and mild cognitive impairment: are we there yet?

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002060

Peripheral cells as an investigational tool for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002060

Cerebrospinal fluid protein biomarkers for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002060

CSF biomarkers for Alzheimer's disease: use in early diagnosis and evaluation of drug treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002060

CSF biomarkers for Alzheimer's Disease: levels of beta-amyloid, tau, phosphorylated tau relate to clinical symptoms and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002060

Identification of a mutant-like conformation of p53 in fibroblasts from sporadic Alzheimer's disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002060

21 January 2018

p53: puzzle and paradigm

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002060

p53, the cellular gatekeeper for growth and division

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002060

The complexity of p53 modulation: emerging patterns from divergent signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002060

Induction of tumour-suppressor phosphoprotein p53 in the apoptosis of cultured rat cerebellar neurones triggered by excitatory amino acids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002060

Hippocampal Myc and p53 expression following transient global ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002060

p53 is present in synapses where it mediates mitochondrial dysfunction and synaptic degeneration in response to DNA damage, and oxidative and excitotoxic insults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002060

p53-dependent cell death signaling in neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002060

Differences between laboratory strains of Epstein-Barr virus based on immortalization, abortive infection, and interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002060

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002060

Parkinsonism: onset, progression, and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002060

Abnormal pattern of platelet APP isoforms in Alzheimer disease and Down syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002060

Altered amyloid protein processing in platelets of patients with Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002060

Platelet amyloid precursor protein processing: a bio-marker for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002060

Amyloid precursor protein in platelets of patients with Alzheimer disease: effect of acetylcholinesterase inhibitor treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002060

Platelet amyloid precursor protein abnormalities in mild cognitive impairment predict conversion to dementia of Alzheimer type: a 2-year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002060

Mild cognitive impairment: prevalence, prognosis, aetiology, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002060

A synthetic inhibitor of p53 protects neurons against death induced by ischemic and excitotoxic insults, and amyloid beta-peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002060

inferred from DOI database lookup

7 January 2021

based on heuristic

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002060

inferred from DOI database lookup

7 January 2021

based on heuristic

Differential Level of Platelet Amyloid beta Precursor Protein Isoforms: An Early Marker for Alzheimer Disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002060

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.MP.4002060

1 reference

17 April 2018

1 reference

17 April 2018